These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11730708)

  • 41. Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.
    Iredale PA; Terwilliger R; Widnell KL; Nestler EJ; Duman RS
    Mol Pharmacol; 1996 Nov; 50(5):1103-10. PubMed ID: 8913341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analgesic effect of corticotropin releasing factor (CRF) on somatic pain sensitivity: participation of glucocorticoid and CRF-2 receptors].
    Iarushkina NI; Bagaeva TR; Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2008 Oct; 94(10):1118-25. PubMed ID: 19065825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral urocortin delays gastric emptying: role of CRF receptor 2.
    Nozu T; Martinez V; Rivier J; Taché Y
    Am J Physiol; 1999 Apr; 276(4):G867-74. PubMed ID: 10198329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of corticotropin-releasing factor on the cortical EEG are reduced following adolescent nicotine exposure.
    Slawecki CJ; Ehlers CL
    Neuropeptides; 2003 Feb; 37(1):66-73. PubMed ID: 12637038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary.
    Aubry JM; Turnbull AV; Pozzoli G; Rivier C; Vale W
    Endocrinology; 1997 Apr; 138(4):1621-6. PubMed ID: 9075723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term potentiation protects rat hippocampal slices from the effects of acute hypoxia.
    Youssef FF; Addae JI; McRae A; Stone TW
    Brain Res; 2001 Jul; 907(1-2):144-50. PubMed ID: 11430897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors.
    Kohman RA; Tarr AJ; Sparkman NL; Day CE; Paquet A; Akkaraju GR; Boehm GW
    Brain Behav Immun; 2007 Aug; 21(6):824-35. PubMed ID: 17339098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Corticotropin-releasing factor (CRF) induces desensitization of the rat pituitary CRF receptor-adenylate cyclase complex.
    Wynn PC; Harwood JP; Catt KJ; Aguilera G
    Endocrinology; 1988 Jan; 122(1):351-8. PubMed ID: 2826113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-lasting increase in cellular excitability associated with the priming of LTP induction in rat hippocampus.
    Cohen AS; Coussens CM; Raymond CR; Abraham WC
    J Neurophysiol; 1999 Dec; 82(6):3139-48. PubMed ID: 10601447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.
    Schulz DW; Mansbach RS; Sprouse J; Braselton JP; Collins J; Corman M; Dunaiskis A; Faraci S; Schmidt AW; Seeger T; Seymour P; Tingley FD; Winston EN; Chen YL; Heym J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10477-82. PubMed ID: 8816826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Working Memory Impairing Actions of Corticotropin-Releasing Factor (CRF) Neurotransmission in the Prefrontal Cortex.
    Hupalo S; Berridge CW
    Neuropsychopharmacology; 2016 Oct; 41(11):2733-40. PubMed ID: 27272767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of corticoliberin at different concentrations on long-term potentiation in slices of rat olfactory cortex.
    Lyubimov YE; Izvaidna NL; Emel'yanov NA; Chikhman VN; Solnushkin SD
    Neurosci Behav Physiol; 2002; 32(6):609-12. PubMed ID: 12469888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro).
    Nikolarakis KE; Almeida OF; Herz A
    Brain Res; 1986 Dec; 399(1):152-5. PubMed ID: 2879612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of corticotropin-releasing factor receptor-2 in stress-induced suppression of pulsatile luteinizing hormone secretion in the rat.
    Li XF; Bowe JE; Lightman SL; O'Byrne KT
    Endocrinology; 2005 Jan; 146(1):318-22. PubMed ID: 15388651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotection by corticotropin releasing factor during hypoxia in rat brain.
    Fox MW; Anderson RE; Meyer FB
    Stroke; 1993 Jul; 24(7):1072-5; discussion 1075-6. PubMed ID: 8322382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons.
    Aldenhoff JB; Gruol DL; Rivier J; Vale W; Siggins GR
    Science; 1983 Aug; 221(4613):875-7. PubMed ID: 6603658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.